Our Speakers
Become A Speaker
Achim Treumann
KBi biopharma BV KBi biopharma BV
Director of Ana... Director of Analytical Formulation Sciences, Site Head
Show Bio
Achim Treumann
KBi biopharma BV
Director of Analytical Formulation Sciences, Site Head
Achim Treumann is an analytical biochemist with a strong interest in the characterization of biological macromolecules, including proteins and large oligosaccharide structures. Following a PhD in Michael Ferguson's laboratory at the University of Dundee, Scotland, he worked in academic and commercial environments as a leader of protein analytical laboratories in Japan, Scotland, England, Ireland and Belgium. Currently he is Principal Scientist Mass Spectrometry at KBI Biopharma BV in Leuven, Belgium.
Maria Crespo
CSL Behring CSL Behring
Director of Bio... Director of Bioprocess Development
Show Bio
Maria Crespo
CSL Behring
Director of Bioprocess Development
Maria Crespo is a director of Bioprocess Development within CSL Behring Bern. She has experience in leading and coordinating technology projects for the development of biological drug candidates. She is responsible for planning and supervising the development activities from lab-scale, up to pilot-scale to establish robust and scalable purification processes for drug development candidates to be transferred to GMP production. She has experience as CMC representative in cross-functional Project Teams; supporting technology transfer of relevant processes to external CMO's.
Matthew Moran
BioPharmaChem Irelan... BioPharmaChem Ireland
Director Director
Show Bio
Matthew Moran
BioPharmaChem Ireland
Director
Matthew Moran is Director of BioPharmaChem Ireland. He graduated in Chemistry at Trinity College Dublin in 1980 and in Chemical Engineering at University College Dublin in 1981; he holds an MBA also from University College Dublin (Smurfit School of Business). He worked for over ten years in the pharmaceutical industry where he held a number of management positions both in active ingredient and dosage form manufacture. He is a member the European Chemical Industry Council (CEFIC). Matthew Moran is a Board member of the Active Pharmaceuticals Ingredients (API) Committee of CEFIC (CEFIC/APIC) and The European Association for Bioindustries (Europabio)
BioPharmaChem Ireland represents the interests of the biopharmachem sector in Ireland. CEFIC/APIC represents the European API Industry. Europabio represents the European Biotech Sector.
Qifeng Zhang
Lonza AG Lonza AG
Global Senior P... Global Senior Principal Scientist
Show Bio
Qifeng Zhang
Lonza AG
Global Senior Principal Scientist
Qifeng Zhang is a Global Senior Principal Scientist, focusing on novel protein therapeutics developability assessment and analytical strategy for product and process development from DNA sequence optimization to commercial release.
Qifeng earned his bachelor degree in biology in 1993 and PhD in analytical organic chemistry in 1998 from the Chinese Academy of Sciences.
Prior to joining Lonza, Qifeng successfully built up and led biopharma formulation and analytics development business with colleagues for former CMC development employer based on DoE-centered QbD strategy. Qifeng’s work in academia mainly concentrated on chromatographic purification of physiologically-active biomolecules and development of pioneering analytics for biological signaling, metabolism and immuno-oncology research.
Leveraging from his unique background, Qifeng passionately advocates for knowledge-driven CMC development strategy based on in-depth understanding of the molecule’s intended medical indications, physicochemical and biological properties, and potential interactions with neighboring components in vitro during manufacturing and in vivo post administration.
Sarah Fadda
Siemens Process Syst... Siemens Process Systems Engineering
Upstream Biopro... Upstream Bioprocessing Practice Director
Show Bio
Sarah Fadda
Siemens Process Systems Engineering
Upstream Bioprocessing Practice Director
Dr Sarah Fadda, Siemens Process Systems Engineering (SPSE)
Dr Sarah Fadda is the Practice Director for Upstream Bioprocessing in the Formulated Products business unit at SPSE. She obtained her degree in chemical engineering in 2005 at the University of Cagliari (Italy) and her PhD in industrial chemistry and chemical engineering in 2009 at Milano Polytechnic (Italy). Before joining SPSE, Dr Fadda spent eight years working as an academic research associate. Her research focused mainly on modelling heterogeneity in various particulate systems, including biological applications, through population balances. She joined SPSE in 2017 and focuses on developing and applying SPSE's mechanistic and hybrid solutions for upstream bioprocessing.
Sean Feast
Precision Chroma Precision Chroma
CEO CEO
Show Bio
Sean Feast
Precision Chroma
CEO
Dr Sean Feast studied under Professor Conan Fee at the University of Canterbury to help develop Printed Monolith Adsorption (PMA or 3D printed chromatography). After completion of his PhD Sean has founded Precision Chroma, a start-up company that is commercialising PMA for applications in biological therapeutic purification and recombinant proteins for research to name a few. Sean is leading Precision Chroma to further developing and scaling up PMA out of the lab and into a manufacturing setting.
Tobias Hedberg
VERIGRAFT VERIGRAFT
Tissue Engineer Tissue Engineer
Show Bio
Tobias Hedberg
VERIGRAFT
Tissue Engineer
My name is Tobias Hedberg. I hold a Phd in immunology from the University of Gothenburg and my work on dendritic cells and their response to adjuvants. Following my Phd I stayed at the University of Gothenburg for a postdoc position in Jan Holmgren's group working on a new adjuvant for an upgraded version of the cholera vaccine. After my postdoc I spent some time in a large pharmaceutical company before finding my way to VERIGRAFT. I have been employed there since early 2017 and my role in the company lies mainly within R&D/production.
Tobias Rosenkranz
Merck Merck
Associate Direc... Associate Director; Head of Biomolecule Formulation
Show Bio
Tobias Rosenkranz
Merck
Associate Director; Head of Biomolecule Formulation
Tobias Rosenkranz is studying proteins, their folding, function and formulation for almost 15 years. He heads the Biomolecule Formulation R&D team within Process and Formulation Materials. His lab mainly focuses on formulation challenges arising in protein formulations, such as protein viscosity and aggregation. A biophysicist by training, he holds a PhD from the HHU Düsseldorf/Research Centre Jülich. Prior to joining the company in 2017, Tobias was a basic researcher at UIUC (US) and UNSW Australia.
Trevor Castor
Aphios International Aphios International
President and C... President and CEO
Show Bio
Trevor Castor
Aphios International
President and CEO
Dr. Trevor P. Castor, President and CEO, Aphios International, Woburn, MA, has over 30 years of diversified experience in technology and business development, management, marketing and finance in the biotechnology industry. He graduated from the University of California, Berkeley with a Ph.D. in Mechanical Engineering and a MSc in Chemical Engineering, and summa cum laude with a BSc in Chemical Engineering from the University of Toronto, Canada. He studied Business Administration at St. Mary’s College, Brooklyn, NY, and Management, Marketing and Finance at the Harvard University Extension Program, Cambridge, MA. He is the author of over a 100 issued and pending US and international patents on SuperFluids™ pathogen inactivation technologies, other enabling technology platforms and enhanced therapeutic products. He has collaborated with several pharmaceutical and biotechnology companies including Eli Lilly, BMS, Novartis, Pfizer and Merck-Millipore-Sigma.
John Moys
Repligen Corporation Repligen Corporation
Bioprocess Syst... Bioprocess Systems Specialist
Show Bio
John Moys
Repligen Corporation
Bioprocess Systems Specialist
John Moys is a European bioprocess systems specialist for Repligen Europe. He has over 35 years’ experience within the Bio Pharmaceutical and Diagnostics industries, in both up and downstream processing. He has over 25 year experience from the supplier perspective working in sales and technical applications support across the UK, Europe and Asia. Prior to this, he had accrued over 8 years of practical experience within manufacturing, quality control and R&D for the in-vitro diagnostics and antibody manufacturing sectors
Gerald Gellermann
Novartis Novartis
Associate Direc... Associate Director
Show Bio
Gerald Gellermann
Novartis
Associate Director
Gerald currently works as Scientific Officer at Novartis Technical Research and Development (TRD) Biologics. He is member of the Novartis ICHQ12 implementation team and co-leads the TRD biologics QbD and Control Strategy initiative. Prior to joining Novartis, he gained professional experience in CMC and analytical development during his time at Roche and AbbVie. Gerald holds a Master's degree in Biology from the University of Constance and a PhD in Molecular Biology from the University of Jena (both Germany).
Behzad Mahdavi
Ginkgo Bioworks Ginkgo Bioworks
Senior Vice Pre... Senior Vice President, Biopharma Manufacturing and Life Sciences Tools
Show Bio
Behzad Mahdavi
Ginkgo Bioworks
Senior Vice President, Biopharma Manufacturing and Life Sciences Tools
Behzad Mahdavi, Ph.D., MBA, joined Ginkgo Bioworks in August 2022 as Senior Vice President, Biopharma Manufacturing and Life Sciences Tools where he will lead Ginkgo’s commercial efforts in the growing areas of bio-reagents, cell and gene therapies and new biopharmaceutical modalities. Dr. Mahdavi has more than 20 years of experience in developing and leading innovative patient-centric growth strategies in challenging environments in the biopharmaceutical, cell and gene therapy, personalized medicine and life sciences sectors and go-to advisor to technology start-ups and large companies.
He most recently served as Vice President of Global Open Innovation at Catalent Pharma Solutions. Prior to that, he held numerous leadership positions during his 13 years at Lonza. Before that, Dr. Mahdavi was CEO of SAM Electron Technologies. In addition to his company leadership roles, he has also served in multiple Board of Directors and Advisory Board roles. He holds a Chemistry Ph.D. from the University of Sherbrooke, Canada, and an MBA from the University of Quebec in Montreal.
Ben Wilkes
Waters Corporation Waters Corporation
European Biopha... European Biopharma Field Marketing Manager
Show Bio
Ben Wilkes
Waters Corporation
European Biopharma Field Marketing Manager
After graduating from the University of Manchester School of Chemistry, Ben joined Sanofi-Genzyme in Haverhill as a PAT scientist and then Abzena, working on the synthesis of ADC payloads and linkers. Ben then joined Lonza, researching and implementing new and advanced analytical technologies in the biopharmaceutical manufacturing process. Ben is now the Biopharma European Field Marketing Manager, focussing on Waters analytical solutions for bioprocessing.
Letha Chemmalil
Bristol Myers Squibb Bristol Myers Squibb
Scientific Asso... Scientific Associate Director
Show Bio
Letha Chemmalil
Bristol Myers Squibb
Scientific Associate Director
Dr. Letha Chemmalil is serving as as Scientific Associate Director at Bristol Myres Squibb in the Global Process Analytical Sciences & Technology group within the Biological Product Developemt division. Her prior affliations include working for major biopharmacetical companies such as Amgen, Genzyme, Seron, Wyeth and others. Letha’s areas of exertise include, analytical method developmet and protein characterzation utilizing Mass Spectrometry (LC/MS & MALDI-TOF MS) and Biophsical Characterization (CD, DSC, FTIR, Fluorescence Spetroscopy, etc.). Her academic background is spanning in the disciplines of Chemistry and Chemical Engineering. Letha’s passion for Process analytical technology (PAT) was evolved in response to hearing stories shared by industry practitioners in reference to the lack of rapid analytical methods for real-time monitoring and timely control of of CQAs. Round table discossions at variuos PAT consortiums also highlighted the deficite of reliable online analytical tools for suprting QbD driven process development and continuous bioprocessing. Letha believes that majority of the offline analytical methods can be performed at the online mode with an appropriate interface. Continuous evolution of chromatographic systems and column chmistries enable significant reduction in analysis time. With such padigm shifts, online chromatographic methods will surpass the spectroscopic methods that are calibrated against chromatographic method for predictive model building.
Chris Berridge
Ecolab Ecolab
Global Technica... Global Technical Consultant, Bioquell Specialist
Show Bio
Chris Berridge
Ecolab
Global Technical Consultant, Bioquell Specialist
Chris has more than 9 years working in various roles within bio-decontamination at Ecolab. He has experience working in graded cleanrooms for pharmaceutical manufacturing as well as biosafety laboratories and biomedical facilities. In his current role, Chris is the Bioquell range specialist in Ecolab’s team of Global Technical Consultants where he is a technical subject matter expert on Bioquell hydrogen peroxide vapor bio-decontamination technology, products and services and their uses in the Life Sciences and Healthcare markets. This involves providing technical sales support to global field sales teams to assist with new and existing opportunities, as well as delivering presentations and educational content about specific products or applications to customers. Chris also manages projects focussing on the implementation of the more complex integrated bio-decontamination systems including detailed design, building of bespoke documentation, and managing the validation and other siteworks. In his role as Global Technical Consultant, Chris also presents at industry events and webinars and provides technical thought leadership to audiences of the various life sciences sectors where hydrogen peroxide vapour bio-decontamination is prevalent.
Christoph Herwig
TU WIEN TU WIEN
Head Research A... Head Research Area Bioprocess Technology
Show Bio
Christoph Herwig
TU WIEN
Head Research Area Bioprocess Technology
Christoph Herwig, bioprocess engineer from RWTH Aachen, worked in industry in the design and commissioning of large chemical facilities prior to enter his interdisciplinary PhD studies at EPFL, Switzerland in bioprocess identification. Subsequently he positioned himself at the interface between bioprocess development and facility design in biopharmaceutical industry. Since 2008, he is full professor for biochemical engineering at the Vienna University of Technology. The research area focuses on the development of data science methods for integrated and efficient bioprocess development along PAT and QbD principles for biopharmaceuticals. In 2013 he founded the company Exputec, which is now part of Körber Pharma, pioneering data science software solutions for the biopharma life cycle.
David Kelaher
Pharmaspectra Pharmaspectra
Chief Medical O... Chief Medical Officer
Show Bio
David Kelaher
Pharmaspectra
Chief Medical Officer
David Kelaher is Chief Medical Officer at Pharmaspectra. David has 20 years of experience in pharmaceutical Medical Affairs and healthcare communications, driving therapeutic portfolio success and international brand growth for several of the world's leading companies, such as Sanofi, Abbvie, and AstraZeneca.
He was previously Managing Director of BBH Health, a specialist strategic and creative business within BBH, one of the world's most awarded agencies. During his five years at the agency, BBH Health became global agency of record for HUMIRA, Symbicort and Brilinta, and led the global brand development and launch campaigns for Fasenra, Skyrizi and Rinvoq. Prior to this, David spent a decade at Sanofi, including Medical Affairs roles in the Australian affiliate, and as a Global Medical Director in the company's Paris headquarters.
He holds a Bachelor of Pharmacy from Sydney University and a Master of Science in Medical Science from Oxford University and is based in Paris.
David Kolwyck
Biogen Idec Biogen Idec
Director Manufa... Director Manufacturing Science - Raw Materials
Show Bio
David Kolwyck
Biogen Idec
Director Manufacturing Science - Raw Materials
David Kolwyck is the Director of the Manufacturing Science team at Solothurn manufacturing site which is a “Next Generation” biologics manufacturing facility leveraging many inline technologies for real-time process monitoring and digitalization of process control. Prior to his current role at Solothurn, he was the Director of the Materials Science team at Biogen. He has been involved in the manufacture pharmaceuticals for >15 yrs and prior to Biogen, he was a Principal Scientist at Amgen. David holds a B. Sci. from Truman State University, M. Sci. from University of Iowa and a M.B.A. from Washington University, St. Louis.
Farzin Farzaneh
King’s College Londo... King’s College London
Professor of Mo... Professor of Molecular Medicine
Show Bio
Farzin Farzaneh
King’s College London
Professor of Molecular Medicine
Having studied at the universities of Aberdeen and Sussex, Farzin’s early career was supported by Fellowships from the Beit Memorial Foundation, MRC and EMBO at universities of Sussex, Amsterdam and King’s College London (KCL). He was appointed to the Chair in Molecular Medicine at KCL in 1996, where he established the Rayne Cell Therapy Suite in 2001. This facility has produced the largest number of viral vectors for regulatory approved clinical studies in Europe (over 100 g-retro and Lenti-viral vectors in the last 5 years). He is also the Chief Scientific Officer at ViroCell Biologics, a recently established innovation driven CDMO, focused on the development and GMP manufacture of viral vectors. His current focus is on the development of vectors for targeted delivery and expression of therapeutic genes, and the rapid transition of gene therapy from discovery science into clinical studies. He holds an Honorary Chair at University College London and at the Technical University of Dresden. He has served since 2016 on the Clinical Trials, Biologicals & Vaccines Expert Advisory Group of the UK Commission on Human Medicines. He received the Distinguished Scientist Award, of the US Society for Experimental Biology and Medicine in 2016.
Viktoria Enkmann
Sciex Sciex
Biopharma Speci... Biopharma Specialist
Show Bio
Viktoria Enkmann
Sciex
Biopharma Specialist
Viktoria has started working with Protein Mass Spectrometry in 2014 and has since filled several positions from hands-on Mass Spectrometry expert at (Bio-)pharmaceutical service providers to Business Development and is now working as a Biopharma Specialist in the DACH region at SCIEX.
Her background in Mass Spectrometry & Drug Development allow for an understanding of past, current and future challenges in the characterization of Biotherapeutics via (LC-)MS.
About The Event (#bioproceseu)
The phenomenal success of biological products in recent years has driven substantial advances in the science and technology surrounding bioreactors and bioprocessing. The rapidity of change and growing demand to fulfil market needs have created imperatives for increased capacity and efficiency, and for reduced production costs and batch-production timeframes. There is also a constant drive to attain adequate yields and meet the necessary standards of purification and stabilisation. Furthermore, emergent areas of research, such as tissue engineering, are often accompanied by their own complex and unique challenges. Alongside the issues of process development, maintenance and scale-up, there are stringent requirements to comply with regulatory standards.
Read more
35+
Speakers
150+
Attendees
10+
Sponsors
Event Partners
Our Sponsors and Partners
Leadvent Startup Innovate
Get your solution and product noticed by showcasing your tech products and pitching to a large-scale targeted audience.
There are two ways to participate in Startup Innovate: either as a paid exhibitor or Free marketing partner. As a marketing partner, you will be required to announce the event on your company website, release article about the event, release email marketing campaigns to reach out for potential delegates and send dedicated social media posts on Linkedin , Twitter& other SM handle. Learn more.
MEDIA PARTNER
FEATURED COMPANIES
Event Inclusions
Case Study Presentations
Giving practical and actionable insights.
Strategic Panel Discussions
Discuss and debate strategies with your peers and most knowledgeable experts
Networking Drinks Receptions
Network face to face with the world’s top executives and rapidly build a network of new business relationships
Content Focused Roundtables
That will provide you with an opportunity for you to not only further engage with key topics but also network with the...
Lead Generation
Establish connections with senior-level representatives from developers, investors & financiers
Content and Recordings
Access to all recordings after the event is over and all presentation slides!
Event Details
About the event
Bioprocessing is the development and manufacturing pipeline by which therapeutic agents such as engineered recombinant proteins, viral gene therapy vectors and other nanoparticle-based technologies are produced at levels required for commercial distribution. To achieve this end, large-scale cultures using engineered cell lines are grown in bioreactors or through other scalable approaches. These are constantly being refined and evolved to increase volume, product yield and efficiency. The adoption of next generation bioprocessing is reaching a decisive moment as biopharmaceutical companies are seeking new manufacturing methods that are essential to the industry's continued growth and innovation. It is more important than ever for the bioprocessing community to connect with one another, share ideas and strategise. Our event will offer unique insights through intensive research with key industry figures, combined with presentations and panel discussions to bring in-depth and informative content.
Today’s bioprocessing is the base of different emerging industries and technologies, including the production of therapeutic stem cells, gene therapy vectors, and new vaccines. Advances in bioprocessing is a special interest to the industry as it highly shortens the development timeline, improves the final product and increases the productivity of Bio-manufacturing facilities.
In this conference, leaders in biopharmaceutical production will investigate the latest technologies and manufacturing strategies for next generation biologics and advanced therapies. It will mainly focus on main challenges within the field, assessing innovative solutions such as continuous bioprocessing, SUTs, data integrity, PAT and the implementation of industry 4.0, all of which aim to increase the efficiency and yield of therapeutic production whilst maintaining high quality standards.
The International Bioprocessing and Biologics Forum will bring together more than 150+ industry experts from Large Pharma with interest in biotech, biotech, biopharmaceutical companies, contract manufacturing organisations, academic & research institutes, regulatory authorities, and solution providers, to discuss the latest developments, cutting-edge technologies, new challenges and opportunities in bioprocessing and best manufacturing practices to make better biologic drugs cheaper and faster!. So, what’s on the agenda for this year? Here’s a snapshot of what’s in-store on this year’s programme:
- Evolution of Bioprocessing
- Next Generation of Biologics Manufacturing
- Gene Therapy at the Dawn of a New Era
- Impact of Stress Factors on Protein Drug Products
- LCMS Methods in Biologicals Formulation Development and in Quality Control
- 3D Printed Chromatography for Intensification of Downstream Processing of Biologics
- Digital Twins for the Acceleration of the Bioproduct Life Cycle
- How synbio at scale will disrupt the manufacturing of futures
- Many more……
Venue
Willy-Brandt-Platz 3, 12529 Schönefeld, Germany
Berlin
Phone : +4930246497908
Email : [email protected] Get Location
Sales End In
Event Registration For Delegate: Prices and Tickets
ENDUSER
799.5€Sale ends on 30-06-2023
Access to Speakers' Presentation
In-person Access to 2 Days Event
Networking & Interaction
Q&A sessions
1-1 Meetings
Access to participants List
Event Documentation
SERVICE PROVIDER
999.5€Sale ends on 30-06-2023
Access to Speakers' Presentation
Access to Participants List
In-person Access to 2 Days Event
Networking & Interaction
Live Q&A sessions
1-1 Meetings
Event Documentation
GROUP TICKET - MINIMUM OF 3
650€Sale ends on 30-06-2023
Access to Speakers' Presentation
Access to Participants List
In-person Access to 2 Days Event
Networking & Interaction
Live Q&A sessions
1-1 Meetings
Event Documentation
VIRTUAL PASS
999€Sale ends on 30-06-2023
Access to Speakers' Presentation
Access to 2 Days Virtual Event
Virtual Networking & Interaction
Q&A sessions
1-1 Meetings
Access to participants List
Event Documentation
Event Registration For Sponsor: Prices and Tickets
BRONZE SPONSOR
5500€Sale ends on 30-06-2023
Acknowledgement as a bronze sponsor
Number of attendee : 2
Speaking slot: 30 Minute
Banner Display
Logo on the event website & brochure
Social media acknowledgement and recognition
Promotional material distribution and display
Full access to delegate list
EXHIBITOR
3000€Sale ends on 30-06-2023
Acknowledgement as a Exhibitor
1 complimentary in-person ticket
Banner Display
Logo on the event website & brochure
Social media acknowledgement and recognition
Exhibition 2X2 Space
EXHIBITOR PLUS
3750€Sale ends on 30-06-2023
Acknowledgement as a Exhibitor Plus
2 complimentary in-person tickets
Banner Display
Logo on the event website & brochure
Social media acknowledgement and recognition
Exhibition 2X2 Space
EXHIBITOR PREMIUM
4500€Sale ends on 30-06-2023
Acknowledgement as a Exhibitor Premium
3 complimentary in-person tickets
Banner Display
Logo on the event website & brochure
Social media acknowledgement and recognition
Exhibition 2X2 Space
Full access to delegate list
I'm not ready to register! That's OK, find more information from our team! CLICK HERE!
Money Back Guarantee
The world has a new way of working, a new scenario but Leadvent Group has always been at the forefront. All our events are backed by the ticket protection, giving your peace of mind.
If covid-19 restrictions emerge in Germany, meaning that we cannot host an in-person gathering, or you face legal travel restrictions, you will be able a full refund for your ticket or partial refund alongside attendance to the virtual event.
We have always covered ticket protection, giving you certainty uncertain times
To view our full terms & conditions, please visit here or contact us
International Bioprocessing and Biologics Highlights
The Bioprocessing and Biologics event has become a MUST ATTEND event for all biotechnology companies
Related Videos
Our Clients Opinion
What Our Customers Say
Projects Developer / Asset Manager, aventron
Head Data Analytics & Business Excellence, Suzlon Global Services Limited
CISO Group Network Manager, Madison Insurance Kenya Limited
Partner, Everoze
